Zobrazeno 1 - 10
of 194
pro vyhledávání: '"Thomas V. Bilfinger"'
Publikováno v:
Journal of Clinical and Translational Science, Vol 7 (2023)
Externí odkaz:
https://doaj.org/article/4fcd136d4d204f87bdf2d8fe894ad5ee
Autor:
Edvard Skripochnik, Ali Reza Sattari, Thomas V. Bilfinger, Apostolos K. Tassiopoulos, Mohsen Bannazadeh
Publikováno v:
EJVES Short Reports, Vol 46, Iss , Pp 2-4 (2020)
Background: Aortic injuries during non-aortic related procedures are rare but potentially catastrophic. Endovascular aortic repair has been described as a viable option in similar circumstances. However, most reports involve aortic injury from orthop
Externí odkaz:
https://doaj.org/article/ed8f26ad376544f188fb6f6ffb789649
Publikováno v:
Pulmonary Medicine, Vol 2019 (2019)
Purpose. Healthy patients with unilateral diaphragm paralysis (UDP) are often asymptomatic; those with UDP and comorbidities that increase work of breathing are often dyspneic. We report the effect of obesity on exercise capacity in UDP patients. Met
Externí odkaz:
https://doaj.org/article/d5ed79e80bf64b5c95b6c50686c2cc2f
Autor:
Heather A. Levites, BS, Omer E. Kaymakcalan, MD, Brett T. Phillips, MD, MBA, Thomas V. Bilfinger, MD, Alexander B. Dagum, MD
Publikováno v:
Plastic and Reconstructive Surgery, Global Open, Vol 2, Iss 10, p e233 (2014)
Externí odkaz:
https://doaj.org/article/7267caa265a64281b954331f9d4fd762
Publikováno v:
Journal of Clinical and Translational Science. 7
Autor:
Nicholas Hanna, Thomas V. Bilfinger, Paul C. Gordon, Scott Buchanan, Toby Rogers, Ron Waksman, Giorgio A. Medranda, Cheng Zhang, Itsik Ben-Dor, Rebecca Torguson, Corey Shea, Hector M. Garcia-Garcia, Gaby Weissman, Maurice Buchbinder, Sean R. Wilson, Federico M. Asch, Robert Levitt, Lowell F. Satler, Afshin Ehsan, Christian Shults, Chiwon Hahn, David Butzel, Puja B. Parikh
Publikováno v:
American Heart Journal. 237:25-33
Background Previous studies from the Low Risk TAVR (LRT) trial demonstrated that transcatheter aortic valve replacement (TAVR) is safe and feasible in low-risk patients, with excellent 30-day and 1-year outcomes. The objective of this study was to re
Autor:
Allison J. McLarty, Kathleen Dhundale, Lee Ann Santore, Mohammad Noubani, Thomas V. Bilfinger, Frank C. Seifert, James W Schurr, Andrew P. Rabenstein
Publikováno v:
The International Journal of Artificial Organs. 44:787-790
The survival after veno-arterial extracorporeal membrane oxygenation score and its lactate modification predict in-hospital mortality in patients based on pre-extracorporeal membrane oxygenation variables. Cardiac arrest history is a significant vari
Publikováno v:
Journal of Vascular Surgery. 73:850-855
Lung cancer and abdominal aortic aneurysms (AAAs) possess multiple shared risk factors. Whereas both have screening guidelines in place, they vary in methodology despite having significant overlap in populations of patients screened.Our hospital syst
Autor:
Christian Shults, Vinod H. Thourani, Quan Zou, Paige Craig, Rebecca Torguson, Petros Okubagzi, Toby Rogers, Scott Buchanan, John Goncalves, Robert Garrett, Ron Waksman, Paul J. Corso, Chiwon Hahn, Thomas V. Bilfinger, Afshin Ehsan
Publikováno v:
Cardiovascular Revascularization Medicine. 21:959-963
The advent of transcatheter aortic valve replacement (TAVR) has changed which patients undergo surgical aortic valve replacement (SAVR). We sought to understand the impact of TAVR on the characteristics of SAVR patients in the United States.A cohort
Autor:
Christian Shults, Chiwon Hahn, Paige Craig, Itsik Ben-Dor, Federico M. Asch, David Roberts, Michael Ingram, Thomas V. Bilfinger, Rebecca Torguson, Puja B. Parikh, Afshin Ehsan, George M. Comas, Gaby Weissman, Robert Levitt, Lowell F. Satler, Toby Rogers, Cheng Zhang, Daniel Ruiz, Ron Waksman, Nicholas Hanna, Hector M. Garcia-Garcia, Paul C. Gordon
Publikováno v:
JACC: Cardiovascular Interventions. 13:1019-1027
Objectives The aim of this study was to evaluate clinical outcomes and transcatheter heart valve hemodynamic parameters after transcatheter aortic valve replacement (TAVR) in low-risk patients with bicuspid aortic stenosis (AS). Background TAVR is ap